Filing Details
- Accession Number:
- 0001179110-21-009609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-25 17:30:32
- Reporting Period:
- 2021-10-22
- Accepted Time:
- 2021-10-25 17:30:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1842952 | Context Therapeutics Inc. | CNTX | Pharmaceutical Preparations (2834) | 472566423 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1861989 | A. Martin Lehr | 3675 Market Street Suite 200 Philadelphia PA 19104 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-22 | 10,000 | $5.00 | 99,583 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-22 | 52,680 | $7.14 | 52,680 | No | 4 | O | Indirect | Martin Lehr 2000 Trust |
Common Stock | Acquisiton | 2021-10-22 | 210,722 | $0.00 | 263,402 | No | 4 | C | Indirect | Martin Lehr 2000 Trust |
Common Stock | Acquisiton | 2021-10-22 | 586,476 | $0.00 | 849,878 | No | 4 | C | Indirect | Martin Lehr 2000 Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | O | Indirect | Martin Lehr 2000 Trust |
No | 4 | C | Indirect | Martin Lehr 2000 Trust |
No | 4 | C | Indirect | Martin Lehr 2000 Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to buy) | Acquisiton | 2021-10-22 | 52,680 | $0.00 | 52,680 | $7.14 |
Common Stock | Series A Preferred Stock | Disposition | 2021-10-22 | 210,722 | $0.00 | 210,722 | $0.00 |
Common Stock | Series Seed Preferred Stock | Disposition | 2021-10-22 | 586,476 | $0.00 | 586,476 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-12-20 | 2030-12-20 | No | 4 | O | Indirect |
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- Fully vested.
- Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.